(ρ<0.001). In G2, all cytokines in supernatant of MO and PBMC cultures, with and without stimulus, showed: M1>M2>M3 (ρ<0.01). Levels of globulins, CRP, AGP, and ESR in patients with pulmonary tuberculosis before treatment (M1) were significantly higher than reference values, suggesting their use as diagnostic markers and indicators of treatment. The CRP decreasing values along treatment could be taken as a marker of the regression of inflammatory process and of response to treatment in patients with pulmonary tuberculosis. Regarding cytokines, there was significant increase in TNF-α, IFN-γ, IL-10, and TGF-β levels before and at three months treatment, with and without stimulus; in TNF-α and IL-10 levels, with and without stimulus, as well as in TGF-β levels without stimulus at six months. Patients had higher levels of all studied cytokines than controls before treatment, and these values decreased along treatment. In this study, pulmonary tuberculosis patients showed a Th0 cytokine profile before treatment, with the production of both Th1 (IFN-γ) and Th2 (IL-10) cytokines, in addition to TNF-α inflammatory and TGF-β regulatory and fibrosis-inducer cytokines. At the end of treatment, all had evolved to Th2 profile, probably in an attempt to reduce the harmful effects of the proinflammatory activity of the Th1 cytokine profile and of the still above-normal levels of TNF-α. The high levels of TGF-β, also found in these patients, are related to its important role in the extracellular matrix deposition and fibrosis induction that characterize tuberculosis healing process. IFN-γ was the only cytokine reaching normal levels at the end of treatment, which suggests its use as a marker of response to treatment.
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